ASE Technology
ASX
43.77
-1.43
-3.16%
ASE Technology
US · ASX
#192 by market cap
Listed 2000
-3.16%
43.77
-1.43
-3.16%
Live - 304 symbols - heartbeat 267s ago
· 2026-09-23 14:10
Pre-market
44.27
-2.06%
After-hours
45.20
0.00%
Overnight
44.00
-2.65%
- Market cap
- 97.85B
- P/E (TTM)i
- 53.19
- P/Bi
- 7.97
- EPSi
- 0.55
- Div yieldi
- 0.95%
- 52W posi
- 96%
Reader sentiment
Are you bullish or bearish on ASX?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 8 years
Latest year +8.39% YoY
Margins
- Gross margin
- 17.69%
- Operating margin
- 7.99%
- Net margin
- 6.20%
Key ratios & quality
- Enterprise valuei
- 251.65B
- Altman Z-Scorei
- 1.29
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.29, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 371.09B | 413.18B | 476.98B | 570.00B | 670.87B | 581.91B | 595.41B | 645.39B |
| Gross profit | 61.16B | 64.31B | 77.98B | 110.37B | 134.93B | 91.76B | 96.93B | 114.19B |
| Selling & admin expenses | 19.55B | 22.39B | 23.81B | 27.19B | 30.38B | 25.93B | 28.94B | 30.59B |
| Research & development | 14.96B | 18.40B | 19.30B | 21.05B | 24.37B | 25.50B | 28.83B | 32.85B |
| Operating profit | 27.44B | 24.11B | 36.56B | 63.96B | 81.54B | 41.88B | 40.41B | 51.53B |
| Pretax profit | 31.94B | 23.28B | 35.77B | 80.19B | 81.76B | 42.61B | 41.73B | 51.30B |
| Tax | 4.51B | 5.01B | 7.12B | 17.94B | 17.15B | 5.30B | 7.92B | 10.11B |
| Net profit | 27.42B | 18.27B | 28.65B | 62.25B | 64.62B | 37.31B | 33.82B | 41.20B |
| Basic EPS | 12 | 8 | 13 | 28 | 29 | 17 | 15 | 18 |
| Diluted EPS | 12.14 | 7.82 | 12.34 | 27.08 | 27.62 | 16.08 | 14.40 | 17.50 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 148.15B | 150.75B | 168.57B | 177.92B | 173.66B | 191.06B |
| Gross profit | 24.89B | 25.69B | 28.88B | 34.74B | 34.85B | 40.15B |
| Selling & admin expenses | 7.64B | 7.49B | 7.37B | 8.08B | 8.11B | 8.79B |
| Research & development | 7.58B | 8.00B | 8.31B | 8.96B | 9.21B | 10.23B |
| Operating profit | 9.86B | 10.19B | 13.20B | 18.47B | 17.61B | 21.13B |
| Pretax profit | 9.81B | 9.26B | 13.98B | 18.26B | 18.20B | 25.70B |
| Tax | 2.02B | 1.58B | 2.62B | 3.89B | 3.64B | 4.17B |
| Net profit | 7.79B | 7.68B | 11.36B | 14.37B | 14.56B | 21.53B |
| Basic EPS | 4 | 3 | 5 | 7 | 6 | 10 |
| Diluted EPS | 3.28 | 3.40 | 4.82 | 6.48 | 6.16 | 9.22 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 201.56B | 202.00B | 224.09B | 292.36B | 300.37B | 261.68B | 275.29B | 313.80B |
| Cash & ST investments | 65.32B | 65.02B | 56.43B | 79.15B | 65.60B | 71.97B | 85.87B | 101.98B |
| Inventory | 46.69B | 45.30B | 62.06B | 73.25B | 92.83B | 63.33B | 61.18B | 69.38B |
| Total assets | 534.06B | 557.22B | 584.15B | 673.27B | 707.59B | 667.39B | 741.06B | 889.50B |
| Total current liabilities | 158.63B | 154.30B | 174.59B | 217.25B | 229.33B | 225.97B | 234.42B | 248.48B |
| Short-term debt | 54.04B | 43.33B | 41.32B | 49.56B | 45.55B | 70.20B | 54.86B | 41.70B |
| Long-term debt | 144.11B | 172.24B | 151.51B | 159.53B | 137.80B | 101.85B | 139.73B | 214.08B |
| Total liabilities | 315,034,005,000.00 | 344,421,394,000.00 | 352,415,528,000.00 | 405,094,839,000.00 | 394,313,457,000.00 | 352,642,080,000.00 | 398,789,156,000.00 | 520,870,658,000.00 |
| Total equity | 219.03B | 212.80B | 231.74B | 268.17B | 313.28B | 314.75B | 342.27B | 368.63B |
| Retained earnings | 20.40B | 21.03B | 30.08B | 69.71B | 91.56B | 89.98B | 96.64B | 108.96B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 278.65B | 254.00B | 294.08B | 313.80B | 337.70B | 360.40B |
| Cash & ST investments | 93.54B | 76.90B | 83.41B | 101.98B | 113.95B | 107.37B |
| Inventory | 59.86B | 57.06B | 66.18B | 69.38B | 76.04B | 86.27B |
| Total assets | 774.18B | 765.18B | 842.64B | 889.50B | 957.53B | 1.07T |
| Total current liabilities | 267.74B | 248.97B | 259.55B | 248.48B | 294.50B | 336.80B |
| Short-term debt | 76.26B | 53.30B | 67.81B | 41.70B | 47.39B | 71.85B |
| Long-term debt | 147.77B | 178.99B | 218.95B | 214.08B | 201.14B | 224.59B |
| Total liabilities | 439,154,000,000.00 | 450,240,000,000.00 | 503,091,000,000.00 | 520,870,658,000.00 | 576,383,490,000.00 | 652,137,000,000.00 |
| Total equity | 335.02B | 314.94B | 339.55B | 368.63B | 381.14B | 419.20B |
| Retained earnings | -- | -- | -- | 108.96B | 97.01B | -- |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 51.07B | 72.30B | 75.06B | 81.73B | 111.00B | 114.42B | 90.79B | 142.25B |
| Depreciation & amortization | 42.69B | 50.47B | 51.26B | 54.52B | 55.45B | 58.10B | 59.82B | 67.44B |
| Free cash flow | 9.11B | 13.79B | 11.88B | 8.80B | 37.30B | 59.83B | 9.11B | -23.60B |
| Dividends paid | -10.61B | -10.62B | -8.52B | -18.08B | -29.99B | -37.84B | -22.46B | -23.03B |
| Stock buybacks / issuance | -71.30M | 0 | 0 | -5.53B | -205.61M | 0 | 0 | -- |
| Ending cash balance | 51.52B | 60.13B | 51.54B | 76.07B | 58.04B | 67.28B | 76.49B | 92.47B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 19.97B | 36.85B | 14.63B | 70.81B | 36.39B | 47.01B |
| Depreciation & amortization | 16.09B | 16.53B | 16.99B | 17.83B | 18.65B | 20.00B |
| Free cash flow | -17.35B | -6.26B | -30.29B | 29.33B | -9.97B | -32.84B |
| Dividends paid | -- | -- | -23.03B | 11.00K | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 77.10B | 72.79B | 75.14B | 92.47B | 87.81B | 91.29B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 13.46 | 8.51 | 12.98 | 25.61 | 22.43 | 12.04 | 10.54 | 12.09 |
| ROA %i | 5.84 | 3.13 | 4.73 | 9.57 | 8.91 | 5.16 | 4.60 | 4.91 |
| ROIC %i | 8.81 | 4.85 | 7.03 | 14.02 | 13.45 | 8.26 | 7.30 | 7.90 |
| 5-year avg ROE %i | 14.03 | 12.43 | 12.41 | 14.77 | 16.60 | 16.31 | 16.72 | 16.54 |
| EBIT margin %i | 9.56 | 6.65 | 8.22 | 14.56 | 12.78 | 8.39 | 8.14 | 9.11 |
| FCF / sales %i | 2.46 | 3.34 | 2.49 | 1.54 | 5.56 | 10.28 | 1.53 | -- |
| Current ratioi | 1.27 | 1.31 | 1.28 | 1.35 | 1.31 | 1.16 | 1.17 | 1.26 |
| Quick ratioi | 0.95 | 0.98 | 0.90 | 0.99 | 0.89 | 0.86 | 0.89 | 0.96 |
| Debt / assetsi | 98.39 | 110.69 | 91.59 | 85.04 | 64.50 | 60.86 | 62.94 | 77.05 |
| LT debt / equityi | 71.56 | 88.96 | 72.47 | 65.50 | 49.05 | 37.02 | 45.79 | 64.87 |
| Interest coveragei | 10.03 | 6.56 | 11.41 | 29.65 | 21.50 | 7.83 | 7.18 | 7.86 |
| Revenue CAGR (3Y) %i | 9.42 | 14.55 | 17.98 | 15.38 | 17.53 | 6.85 | 1.46 | -1.28 |
| Net income CAGR (3Y) %i | 9.94 | -7.17 | 5.73 | 31.89 | 53.33 | 9.55 | -18.65 | -13.35 |
| FCF CAGR (3Y) %i | -30.19 | -17.85 | -19.04 | -1.14 | 39.31 | 71.40 | 1.13 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.38 | 11.41 | 11.22 | 12.09 | 14.08 | 17.61 |
| ROA %i | 4.71 | 4.70 | 4.52 | 4.91 | 5.38 | 6.55 |
| ROIC %i | 7.87 | 7.91 | 7.32 | 7.90 | 8.99 | 11.06 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 8.29 | 8.02 | 8.20 | 9.11 | 10.06 | 11.89 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 1.04 | 1.02 | 1.13 | 1.26 | 1.15 | 1.07 |
| Quick ratioi | 0.76 | 0.72 | 0.81 | 0.96 | 0.86 | 0.74 |
| Debt / assetsi | 71.92 | 79.07 | 90.45 | 77.05 | 73.01 | 76.17 |
| LT debt / equityi | 47.44 | 60.93 | 69.06 | 64.87 | 59.49 | 57.70 |
| Interest coveragei | 7.34 | 7.18 | 7.29 | 7.86 | 8.66 | 10.01 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Packaging52.02%
Electronic manufacturing services (EMS)34.24%
Testing12.39%
Others1.36%
Quote time 2026-09-23 14:10:00 · For reference only, not investment advice.